65,437 trials
Hepatitis C
Primary: Percentage of Participants With Sustained Virologic Response (SVR) at Post-Treatment Follow-up Week 24 (SVR24) — 91.2 Percentage of participants
Alcohol Drinking
Primary: Number of Drinks Consumed at Lab Session (Day 7) — 4.11; 5.02 drinks
Diabetes Mellitus
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) Level at Month 6 — 8.1; -1.2 percentage of glycosylated hemoglobin
Duchenne Muscular Dystrophy (DMD)
Primary: Change From Baseline in the 6 Minute Walk Test (6MWT) at Week 240 — -199.0; -258.0 Meters
Axillary Hyperhidrosis
Primary: Number of Participants With Hyperhidrosis Disease Severity Scale (HDSS) Score Reduction at Day 30 Post Second Treatment — 11 participants
Cerebral Palsy Spastic Diplegia
Primary: Change in Walking Performance High Versus Low Frequency SBLTT Groups — 1872; 1551 strides per day — p=.39
Diabetes · Diabetes Mellitus, Type 2
Primary: Change in HbA1c — -1.00; -0.32; -1.05; -0.35 Percentage of HbA1c — p=<.001
Type 1 Diabetes Mellitus · Pregnancy
Primary: HbA1c — -0.8 HbA1C percentage
Eosinophilic Esophagitis · Milk Allergy
Primary: Change in Maximum Esophageal Eosinophil Count From Baseline to End of Double-blind Treatment. (Intent to Treat Population) — -10.8; -24.2 Eosinophils (Eos)/high power…
Hepatitis C Virus (HCV)
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks Post Treatment (SVR12) — 95.7; 98.4 percentage of participants
Contraception
Primary: Mean Difference Between Pre and Postoperative Hemoglobin (g/dl) — 1.4; 1.8 g/dL — p=0.08
Urinary Bladder, Overactive
Primary: Treatment Phase 1 (Treatment Cycle 1)- Change From Baseline in the Daily Average Number of Urinary Incontinence Episodes at Week 6 — -0.18; -3.20 Episodes
Hypercholesterolemia
Primary: Number of Participants With Adverse Events — 327; 728; 342; 718 Participants
Attention Deficit Hyperactivity Disorder
Primary: Change From Baseline in Conners Continuous Performance Test (CPT) RT Variability Scaled Score — -6.65; 1.84 score on a scale — p=0.026
MDD
Primary: Change in Seizure Threshold — 23.04; 19.68 millicoulombs